EUVIMEDEUVIMED entdecken
Open Access

TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells

Pratik Deb, Sukhwinder Singh, Evelyne Kalyoussef iD, Nicholas J Hess iD, Richard I Tapping iD, Patricia Fitzgerald-Bocarsly iD

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2200468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Pratik Deb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers School of Graduate Studies, Newark, NJ. Hauptthemen laut MEDLINE: Dendritic Cells, Suppressor of Cytokine Signaling 3 Protein, Interferon Regulatory Factor-7, STAT3 Transcription Factor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TLRs are the most thoroughly studied group of pattern-recognition receptors that play a central role in innate immunity. Among them, TLR10 (CD290) remains the only TLR family member without a known ligand and clearly defined functions. One major impediment to studying TLR10 is its absence in mice. A recent study on TLR10 knock-in mice demonstrated its intrinsic inhibitory role in B cells, indicating that TLR10 is a potential drug target in autoimmune diseases. In this study, we interrogated the expression and function of TLR10 in human plasmacytoid dendritic cells (pDCs). We have seen that primary human pDCs, B cells, and monocytes constitutively express TLR10. Upon preincubation with an anti-TLR10 Ab, production of cytokines in pDCs was downregulated in response to stimulation with DNA and RNA viruses. Upon further investigation into the possible mechanism, we documented phosphorylation of STAT3 upon Ab-mediated engagement of TLR10. This leads to the induction of inhibitory molecule suppressor of cytokine signaling 3 (SOCS3) expression. We have also documented the inhibition of nuclear translocation of transcription factor IFN regulatory factor 7 (IRF7) in pDCs following TLR10 engagement. Our data provide the (to our knowledge) first evidence that TLR10 is constitutively expressed on the surface of human pDCs and works as a regulator of their innate response. Our findings indicate the potential of harnessing the function of pDCs by Ab-mediated targeting of TLR10 that may open a new therapeutic avenue for autoimmune disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsSuppressor of Cytokine Signaling 3 ProteinInterferon Regulatory Factor-7STAT3 Transcription FactorToll-Like Receptor 10HumansImmunity, InnateCytokinesCells, CulturedPhosphorylationAnimalsB-LymphocytesSignal TransductionMiceMonocytes

Substanzen

Suppressor of Cytokine Signaling 3 ProteinInterferon Regulatory Factor-7STAT3 Transcription FactorToll-Like Receptor 10IRF7 protein, humanTLR10 protein, humanSOCS3 protein, humanSTAT3 protein, humanCytokines

Autor:innen und Institutionen

  • Rutgers School of Graduate Studies, Newark, NJ.
  • Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ.
  • Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ.
  • Department of Otorhinolaryngology, Rutgers New Jersey Medical School, Newark, NJ.
  • Department of Medical Microbiology & Immunology, University of Wisconsin-Madison, Madison, WI.
  • University of Illinois College of Medicine, Peoria Campus, Peoria, IL.

ORCID-Profile: Evelyne Kalyoussef, Nicholas J Hess, Richard I Tapping, Patricia Fitzgerald-Bocarsly

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NCRR NIH HHS
  • NIH HHS

Zitieren

APA

Deb, P., Singh, S., Kalyoussef, E., Hess, N. J., Tapping, R. I., & Fitzgerald-Bocarsly, P. (2024). TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200468

Vancouver

Deb P, Singh S, Kalyoussef E, Hess NJ, Tapping RI, Fitzgerald-Bocarsly P. TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2200468

BibTeX
@article{Deb2024,
  author = {Deb, Pratik and Singh, Sukhwinder and Kalyoussef, Evelyne and Hess, Nicholas J and Tapping, Richard I and Fitzgerald-Bocarsly, Patricia},
  title = {TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2200468}
}
Kostenlos starten →